Defining the cellular determinants that drive dynamin inhibitor induced cell death and in vivo efficacy against glioblastoma

Dr Megan Chircop

Children's Medical Research Insitute (NSW)

$360,000

2014 - 2016

‍

The Research

This project will investigate if dynamin II inhibitors are valid agents for treatment of brain cancers. This research will identify key dynamin inhibitory compounds with anti-cancer properties, ultimately to be used as a chemotherapy agent.